Take a look for yourself

Published: 29-May-2018
Manufacturing Ingredients

Gnosis releases video showing a virtual tour of the biotechnology manufacturing facility in Pisticci, in Italy


Gnosis have created a new video of its Pisticci Operations, its most recent production site.

FDA and AIFA approved, with HACCP, ISO 22000, Kosher, Halal certifications, this plant is an example of manufacturing excellence achieved through the application of good science and minimising the environmental footprint.

Through an extensive know-how and a remarkable experience in biotech operations, Pisticci plant provides process development, scale up and manufacturing of fermentation-based compounds including Active Pharmaceutical Ingredients (APIs) and Nutraceuticals.

Discover Quatrefolic, VitaMK7, Emothion, Mythocondro and the reliable European supply chain with this video.

  • Companies:
  • Gnosis by Lesaffre
See more

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

Read more
New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond

Trending Articles

  1. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet equally powerful partnership is that of vitamins D3 and K2
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. GOED releases two market research reports: annual global omega-3 ingredient market and consumer search trends The Global Organization for EPA and DHA Omega-3s (GOED) has published two important reports detailing trends in the global EPA and DHA omega-3 industry
  4. How to treat (and supplement) pets like part of the family Globally, 85% of pet parents agree that proper nutrition and supplements are as important for their pets as they are for themselves, writes Guillaume Maio, Marketing Manager, Pet Nutrition, at ADM
  5. New study suggests vitamin K deficiency is the missing link in COVID-19 pathogenesis The review , published in the <i>British Journal of Nutrition</i>, presents vitamin K metabolism as the potential missing link between lung damage and thromboembolism, two of the most serious outcomes observed in COVID-19 patients

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

LifeinU BSCU1: embrace your health now and for the future

New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by Lesaffre, has not only shown proven efficacy for immune support, but exciting new evidence confirms its protective role for immunity and beyond
Ingredients

SAMe holds promise for depression, studies find

Two novel studies have suggested S-Adenosylmethionine (SAMe) could be a beneficial monotherapy for patients with depression
Ingredients

SunWay Biotech and Gnosis by Lesaffre form alliance to launch MenaQ7 Metabolic

The novel product will be aimed at the lucrative vitamin K2 market
Ingredients

Vitamin K2 could be at the heart of a healthy lifestyle

Further evidence highlights the impact of essential nutrients on cardiovascular health, including potential $9.48B a year in healthcare cost savings
Ingredients

Gnosis vitamin K2 scientific advisory committee grows and holds first meeting

The inaugural meeting of the Gnosis K2SAC welcomed new members and focused on the exciting future for K2
Ingredients

Gnosis by Lesaffre launches MenaQ7 Protect

A collaboration between Gnosis and Probiotical creates the first private-label, ready-to-market, immune-support supplement featuring clinically validated MenaQ7 K2
Ingredients

New MenaQ7 K2 cardio study in kidney patients published

TReVasc-HDK Trial examined the efficacy of K2 supplementation in reducing vascular calcification progression in haemodialysis patients, offering new insights on appropriate dosing
Subscribe now